MITOPE: RSO-021, a novel PRX3 inhibitor, in mesothelioma or other pleural cancers

(3:54)

MECHANISM OF ACTION RSO 021

(2:43)

RS Oncology presents new drug in clinical development for Mesothelioma and lung cancer patients

(1:52)

FDA Approval of Setmelanotide for Patients 2 Years and Older With MC4R Pathway Diseases

(13:53)

Dr Mekhail on a Case Study of Early-Stage, Nonmetastatic Lung Cancer

(3:2)

Evaluating the prognostic value of CTCs in patients with myeloma enrolled in the PERSEUS trial

(3:19)

What is Human Metapneumovirus (HMNV)?

(1:39)

[Anatomy], scaphoid, lunate, triquetrum, and pisiform, trapezium, trapezoid, capitate, and hamate

(13)

Redo Mitral Surgery: Onyx Mechanical Mitral Valve Replacement After Previous Mitral Repair

(14:40)

Meet Themistoklis Nissirios, MD

(1:20)

Maîtrisez la Mammographie : Atelier Pratique et Certification 2025

(22)

Long-term outcomes of alloSCT for T-cell prolymphocytic leukemia

(2:7)